Position in PFE
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$467,307
+$51,179 QoQ
Shares Held
16,642
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CIM INVESTMENT MANAGEMENT INC holds $7,573,198 across 8 Drug Manufacturers - General names. PFE ranks #7 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,979 | $1,820,224 | |
| 2 | JNJ |
Johnson & Johnson
|
6,866 | $1,678,325 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,140 | $979,160 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
14,397 | $873,178 | |
| 5 | AMGN |
Amgen Inc
|
2,392 | $841,625 | |
| 6 | BIIB |
Biogen Inc.
|
2,830 | $518,823 | |
| 7 | PFE |
Pfizer Inc
This page
|
16,642 | $467,307 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,831 | $394,556 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $467,307 | 16,642 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $416,128 | 16,712 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $425,821 | 16,712 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $819,457 | 33,806 | Shares | Sole | 2025-08-22 | |
| 2025-03-31 | $429,031 | 16,931 | Shares | Sole | 2025-06-02 | |
| 2024-12-31 | $449,471 | 16,942 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $496,494 | 17,156 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $498,323 | 17,810 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $500,166 | 18,024 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $518,910 | 18,024 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $597,856 | 18,024 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $674,691 | 18,394 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $748,965 | 18,357 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $444,302 | 8,671 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $779,628 | 17,816 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $934,092 | 17,816 | Shares | Sole | 2022-09-02 | |
| 2022-03-31 | $927,200 | 17,910 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,058,648 | 17,928 | Shares | Sole | 2022-05-19 | |
| 2021-09-30 | $831,770 | 19,339 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $706,521 | 19,501 | Shares | Sole | 2021-05-20 | |
| 2020-12-31 | $745,844 | 20,262 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $755,762 | 20,593 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $680,847 | 20,821 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $704,076 | 21,571 | Shares | Sole | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||